Michelle S Redell

8PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical microbiology not elsewhere classifiedGene and molecular therapyInfant and child healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 30, 2026
Characterization of chemoresistant cell populations improves risk stratification and therapy prediction in pediatric acute myeloid leukemia.

|Nov 13, 2025
Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia Patients Have Dismal Outcomes Irrespective of Allogeneic Hematopoietic Stem Cell Transplant: A Single-Center Experience.

Gabriela Llaurador, Matthew Willis, Michele S Redell

|May 14, 2025
Magrolimab Therapy in Conjunction with Conventional Chemotherapeutics Slows Disease Progression in Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Models.

Julia G Kim, Sohani K Sandhu, Ritesh V Dontula

|Nov 30, 2023
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

Erica Brivio, Edoardo Pennesi, Marieke E Willemse

|Jul 15, 2022
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report.

Alexandra M Stevens, Terzah M Horton, Chana L Glasser

|May 05, 2021
Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia.

P Narayanan, T-K Man, R B Gerbing

Pageof 2

Frequent Collaborators

3 joint publications

Alexandra M Stevens

1 joint publications

Erica Brivio

1 joint publications

Edoardo Pennesi

1 joint publications

Harm D R van Tinteren